title: Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.
abstract: OBJECTIVE
  To make recommendations on how to report disease activity in clinical trials of rheumatoid arthritis (RA) endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).
  
  
  METHODS
  The project followed the EULAR standardised operating procedures, which use a three-step approach: (1) expert-based definition of relevant research questions (November 2006); (2) systematic literature search (November 2006 to May 2007); and (3) expert consensus on recommendations based on the literature search results (May 2007). In addition, since this is the first joint EULAR/ACR publication on recommendations, an extra step included a meeting with an ACR panel to approve the recommendations elaborated by the expert group (August 2007).
  
  
  RESULTS
  Eleven relevant questions were identified for the literature search. Based on the evidence from the literature the expert panel recommended that each trial should report the following items: (1) disease activity response and disease activity states; (2) appropriate descriptive statistics of the baseline, the endpoints and change of the single variables included in the core set; (3) baseline disease activity levels (in general); (4) the percentage of patients achieving a low disease activity state and remission; (5) time to onset of the primary outcome; (6) sustainability of the primary outcome; (7) fatigue.
  
  
  CONCLUSIONS
  These recommendations endorsed by EULAR and ACR will help harmonise the presentations of results from clinical trials. Adherence to these recommendations will provide the readership of clinical trials with more details of important outcomes, while the higher level of homogeneity may facilitate the comparison of outcomes across different trials and pooling of trial results, such as in meta-analyses.
authors.affiliation: Division of Rheumatology, Medical University of Vienna, Vienna, Austria. daniel.aletaha@meduniwien.ac.at
authors.forename: D
authors.initials: D
authors.lastname: Aletaha
authors.forename: R
authors.initials: R
authors.lastname: Landewe
authors.forename: T
authors.initials: T
authors.lastname: Karonitsch
authors.forename: J
authors.initials: J
authors.lastname: Bathon
authors.forename: M
authors.initials: M
authors.lastname: Boers
authors.forename: C
authors.initials: C
authors.lastname: Bombardier
authors.forename: S
authors.initials: S
authors.lastname: Bombardieri
authors.forename: H
authors.initials: H
authors.lastname: Choi
authors.forename: B
authors.initials: B
authors.lastname: Combe
authors.forename: M
authors.initials: M
authors.lastname: Dougados
authors.forename: P
authors.initials: P
authors.lastname: Emery
authors.forename: J
authors.initials: J
authors.lastname: Gomez-Reino
authors.forename: E
authors.initials: E
authors.lastname: Keystone
authors.forename: G
authors.initials: G
authors.lastname: Koch
authors.forename: T K
authors.initials: TK
authors.lastname: Kvien
authors.forename: E
authors.initials: E
authors.lastname: Martin-Mola
authors.forename: M
authors.initials: M
authors.lastname: Matucci-Cerinic
authors.forename: K
authors.initials: K
authors.lastname: Michaud
authors.forename: J
authors.initials: J
authors.lastname: O'Dell
authors.forename: H
authors.initials: H
authors.lastname: Paulus
authors.forename: T
authors.initials: T
authors.lastname: Pincus
authors.forename: P
authors.initials: P
authors.lastname: Richards
authors.forename: L
authors.initials: L
authors.lastname: Simon
authors.forename: J
authors.initials: J
authors.lastname: Siegel
authors.forename: J S
authors.initials: JS
authors.lastname: Smolen
authors.forename: T
authors.initials: T
authors.lastname: Sokka
authors.forename: V
authors.initials: V
authors.lastname: Strand
authors.forename: P
authors.initials: P
authors.lastname: Tugwell
authors.forename: D
authors.initials: D
authors.lastname: van der Heijde
authors.forename: P
authors.initials: P
authors.lastname: van Riel
authors.forename: S
authors.initials: S
authors.lastname: Vlad
authors.forename: R
authors.initials: R
authors.lastname: van Vollenhoven
authors.forename: M
authors.initials: M
authors.lastname: Ward
authors.forename: M
authors.initials: M
authors.lastname: Weinblatt
authors.forename: G
authors.initials: G
authors.lastname: Wells
authors.forename: B
authors.initials: B
authors.lastname: White
authors.forename: F
authors.initials: F
authors.lastname: Wolfe
authors.forename: B
authors.initials: B
authors.lastname: Zhang
authors.forename: A
authors.initials: A
authors.lastname: Zink
authors.forename: D
authors.initials: D
authors.lastname: Felson
mesh_terms: D001172:Arthritis, Rheumatoid / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards*; D019317:Evidence-Based Medicine / Q000379:methods; D005221:Fatigue / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D007391:International Cooperation; D012074:Remission Induction; D012107:Research Design / Q000592:standards; D012720:Severity of Illness Index; D012955:Societies, Medical; D016896:Treatment Outcome